Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Synthetic Cannabinoid Receptor Agonists
100%
Biased Agonism
100%
Arrestin2
60%
Signaling Pathway
40%
G Protein
40%
Cannabinoid Receptor 1 (CB1R)
40%
Cannabinoid Ligands
40%
Ligand Bias
40%
New Therapeutics
20%
Metabolic Syndrome
20%
Therapeutic Implications
20%
Drug Target
20%
Functional Activity
20%
Chemical Structure
20%
Structural Features
20%
Knowledge Base
20%
Neuropathic Pain
20%
EG-018
20%
CP55940
20%
CUMYL
20%
Functional Complementation
20%
Activity Relationship
20%
5F-APINACA
20%
Different Cell Lines
20%
Neuroscience
Receptor Agonists
100%
Cannabinoid Receptor
100%
Cell Signaling
40%
Agonist
40%
Cannabinoid 1 Receptor
40%
G Protein
20%
Cell Line
20%
Inhibitory Guanine Nucleotide Binding Protein
20%
Neuropathic Pain
20%
Side Effect
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cannabinoid Receptor Agonist
100%
Cannabinoid 1 Receptor
40%
Cannabinoid
40%
Bioassay
20%
Guanine Nucleotide Binding Protein
20%
Base
20%
Psychotropic Agent
20%
Neuropathic Pain
20%
Metabolic Syndrome X
20%
4 (1,1 Dimethylheptyl) 1',2',3',4',5',6' Hexahydro 2,3' Dihydroxy 6' (3 Hydroxypropyl)biphenyl
20%
Inhibitory Guanine Nucleotide Binding Protein
20%
Diseases
20%
Side Effect
20%
Biochemistry, Genetics and Molecular Biology
Receptor Agonists
100%
Cannabinoid Receptor
100%
Signal Transduction
28%
Agonist
28%
Cannabinoid
28%
Chemical Structure
14%
Bioassay
14%
Knowledge Base
14%
G Protein
14%